{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T18:03:59Z","timestamp":1771437839599,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":4,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Natural Science Fundation of Fujian Province","award":["2023J01598"],"award-info":[{"award-number":["2023J01598"]}]},{"DOI":"10.13039\/501100017686","name":"Fujian Provincial Health Technology Project","doi-asserted-by":"publisher","award":["2023QNA024"],"award-info":[{"award-number":["2023QNA024"]}],"id":[{"id":"10.13039\/501100017686","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Joint Funds for the Innovation of Science and Technology,Fujian Province","award":["2025Y9178"],"award-info":[{"award-number":["2025Y9178"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-07814-x","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T13:35:35Z","timestamp":1770903335000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Increased IL4I1 expression predicts poor survival and modulates the immune microenvironment in acute myeloid leukemia"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4179-5001","authenticated-orcid":false,"given":"Jinlong","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liangyong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junfang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guilan","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanquan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqiang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Apeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingjiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinfeng","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junmin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liying","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,12]]},"reference":[{"issue":"1","key":"7814_CR1","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3322\/caac.21873","volume":"75","author":"HM Kantarjian","year":"2025","unstructured":"Kantarjian HM, DiNardo CD, Kadia TM, Daver NG, Altman JK, Stein EM, et al. Acute myeloid leukemia management and research in 2025. Cancer J Clin. 2025;75(1):46\u201367.","journal-title":"Cancer J Clin"},{"issue":"7","key":"7814_CR2","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.tips.2023.04.006","volume":"44","author":"TW Stone","year":"2023","unstructured":"Stone TW, Williams RO. Modulation of T cells by Tryptophan metabolites in the kynurenine pathway. Trends Pharmacol Sci. 2023;44(7):442\u201356.","journal-title":"Trends Pharmacol Sci"},{"key":"7814_CR3","doi-asserted-by":"crossref","unstructured":"Bod L, Douguet L, Auffray C, Lengagne R, Bekkat F, Rondeau E, et al. IL-4-Induced Gene 1: a negative immune checkpoint controlling B cell differentiation and activation. J Immunol. 2018;200(3):1027\u201338.","DOI":"10.4049\/jimmunol.1601609"},{"issue":"3","key":"7814_CR4","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/cas.16073","volume":"115","author":"S Hirose","year":"2024","unstructured":"Hirose S, Mashima T, Yuan X, Yamashita M, Kitano S, Torii S, et al. Interleukin-4 induced 1-mediated resistance to an immune checkpoint inhibitor through suppression of CD8(+) T cell infiltration in melanoma. Cancer Sci. 2024;115(3):791\u2013803.","journal-title":"Cancer Sci"},{"key":"7814_CR5","doi-asserted-by":"publisher","first-page":"1338244","DOI":"10.3389\/fimmu.2023.1338244","volume":"14","author":"F Ye","year":"2023","unstructured":"Ye F, Wang L, Li Y, Dong C, Zhou L, Xu J. IL4I1 in M2-like macrophage promotes glioma progression and is a promising target for immunotherapy. Front Immunol. 2023;14:1338244.","journal-title":"Front Immunol"},{"key":"7814_CR6","doi-asserted-by":"crossref","unstructured":"Molinier-Frenkel V, Pr\u00e9vost-Blondel A, Castellano F. The IL4I1 enzyme: A new player in the immunosuppressive tumor microenvironment. Cells. 2019;8(7).","DOI":"10.3390\/cells8070757"},{"issue":"5","key":"7814_CR7","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/j.cell.2020.07.038","volume":"182","author":"A Sadik","year":"2020","unstructured":"Sadik A, Somarribas Patterson LF, \u00d6zt\u00fcrk S, Mohapatra SR, Panitz V, Secker PF, et al. IL4I1 is a metabolic immune checkpoint that activates the AHR and promotes tumor progression. Cell. 2020;182(5):1252\u2013e7034.","journal-title":"Cell"},{"issue":"1","key":"7814_CR8","doi-asserted-by":"publisher","first-page":"2244330","DOI":"10.1080\/2162402X.2023.2244330","volume":"12","author":"S Schlichtner","year":"2023","unstructured":"Schlichtner S, Yasinska IM, Klenova E, Abooali M, Lall GS, Berger SM, et al. L-Kynurenine participates in cancer immune evasion by downregulating hypoxic signaling in T lymphocytes. Oncoimmunology. 2023;12(1):2244330.","journal-title":"Oncoimmunology"},{"issue":"6","key":"7814_CR9","doi-asserted-by":"publisher","first-page":"104827","DOI":"10.1016\/j.jbc.2023.104827","volume":"299","author":"L Zeitler","year":"2023","unstructured":"Zeitler L, Murray PJ. IL4i1 and IDO1: oxidases that control a tryptophan metabolic nexus in cancer. J Biol Chem. 2023;299(6):104827.","journal-title":"J Biol Chem"},{"issue":"4","key":"7814_CR10","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/nbt.3772","volume":"35","author":"J Vivian","year":"2017","unstructured":"Vivian J, Rao AA, Nothaft FA, Ketchum C, Armstrong J, Novak A, et al. Toil enables reproducible, open source, big biomedical data analyses. Nat Biotechnol. 2017;35(4):314\u20136.","journal-title":"Nat Biotechnol"},{"issue":"1","key":"7814_CR11","first-page":"15","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinf (Oxford England). 2013;29(1):15\u201321.","journal-title":"Bioinf (Oxford England)"},{"issue":"12","key":"7814_CR12","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1182\/blood.2022016867","volume":"140","author":"H D\u00f6hner","year":"2022","unstructured":"D\u00f6hner H, Wei AH, Appelbaum FR, Craddock C, DiNardo CD, Dombret H, et al. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood. 2022;140(12):1345\u201377.","journal-title":"Blood"},{"issue":"2","key":"7814_CR13","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.cell.2018.02.052","volume":"173","author":"J Liu","year":"2018","unstructured":"Liu J, Lichtenberg T, Hoadley KA, Poisson LM, Lazar AJ, Cherniack AD, et al. An integrated TCGA Pan-Cancer clinical data resource to drive High-Quality survival outcome analytics. Cell. 2018;173(2):400\u2013. \u2013\u200916.e11.","journal-title":"Cell"},{"issue":"12","key":"7814_CR14","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated Estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550.","journal-title":"Genome Biol"},{"issue":"D1","key":"7814_CR15","doi-asserted-by":"publisher","first-page":"D605","DOI":"10.1093\/nar\/gkaa1074","volume":"49","author":"D Szklarczyk","year":"2021","unstructured":"Szklarczyk D, Gable AL, Nastou KC, Lyon D, Kirsch R, Pyysalo S, et al. The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene\/measurement sets. Nucleic Acids Res. 2021;49(D1):D605\u201312.","journal-title":"Nucleic Acids Res"},{"issue":"43","key":"7814_CR16","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102(43):15545\u201350.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"7814_CR17","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. ClusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284\u20137.","journal-title":"OMICS"},{"key":"7814_CR18","doi-asserted-by":"crossref","unstructured":"Bailur JK, McCachren SS, Pendleton K, Vasquez JC, Lim HS, Duffy A, et al. Risk-associated alterations in marrow T cells in pediatric leukemia. JCI Insight. 2020;5(16).","DOI":"10.1172\/jci.insight.140179"},{"key":"7814_CR19","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics. 2013;14:7.","journal-title":"BMC Bioinformatics"},{"issue":"4","key":"7814_CR20","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.immuni.2013.10.003","volume":"39","author":"G Bindea","year":"2013","unstructured":"Bindea G, Mlecnik B, Tosolini M, Kirilovsky A, Waldner M, Obenauf AC, et al. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity. 2013;39(4):782\u201395.","journal-title":"Immunity"},{"key":"7814_CR21","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara K, Shahmoradgoli M, Mart\u00ednez E, Vegesna R, Kim H, Torres-Garcia W, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4:2612.","journal-title":"Nat Commun"},{"issue":"1","key":"7814_CR22","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13073-019-0638-6","volume":"11","author":"F Finotello","year":"2019","unstructured":"Finotello F, Mayer C, Plattner C, Laschober G, Rieder D, Hackl H, et al. Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data. Genome Med. 2019;11(1):34.","journal-title":"Genome Med"},{"key":"7814_CR23","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/bs.mie.2019.05.056","volume":"636","author":"C Plattner","year":"2020","unstructured":"Plattner C, Finotello F, Rieder D. Deconvoluting tumor-infiltrating immune cells from RNA-seq data using quantiseq. Methods Enzymol. 2020;636:261\u201385.","journal-title":"Methods Enzymol"},{"issue":"1","key":"7814_CR24","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/s41392-021-00529-z","volume":"6","author":"Z Wang","year":"2021","unstructured":"Wang Z, Li T, Mao C, Liu W, Tao Y. IL4I1-driven AHR signature: a new avenue for cancer therapy. Signal Transduct Target Therapy. 2021;6(1):118.","journal-title":"Signal Transduct Target Therapy"},{"key":"7814_CR25","doi-asserted-by":"crossref","unstructured":"Choueiry F, Singh S, Sircar A, Laliotis G, Sun X, Chavdoula E, et al. Integration of metabolomics and gene expression profiling elucidates IL4I1 as modulator of ibrutinib resistance in ABC-Diffuse large B cell lymphoma. Cancers. 2021;13(9).","DOI":"10.3390\/cancers13092146"},{"issue":"1","key":"7814_CR26","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12902-023-01407-1","volume":"23","author":"L Zhu","year":"2023","unstructured":"Zhu L, Wang J, Hu J. High expression of IL4I1 is correlated with poor prognosis and immune infiltration in thyroid cancer. BMC Endocr Disorders. 2023;23(1):148.","journal-title":"BMC Endocr Disorders"},{"issue":"11","key":"7814_CR27","first-page":"7758","volume":"14","author":"H Sun","year":"2022","unstructured":"Sun H, Han W, Wen J, Ma X. IL4I1 and tryptophan metabolites enhance AHR signals to facilitate colorectal cancer progression and immunosuppression. Am J Translational Res. 2022;14(11):7758\u201370.","journal-title":"Am J Translational Res"},{"key":"7814_CR28","doi-asserted-by":"publisher","first-page":"1440269","DOI":"10.3389\/fimmu.2024.1440269","volume":"15","author":"Y Grobben","year":"2024","unstructured":"Grobben Y. Targeting amino acid-metabolizing enzymes for cancer immunotherapy. Front Immunol. 2024;15:1440269.","journal-title":"Front Immunol"},{"issue":"11","key":"7814_CR29","doi-asserted-by":"publisher","first-page":"e0142979","DOI":"10.1371\/journal.pone.0142979","volume":"10","author":"Y Yue","year":"2015","unstructured":"Yue Y, Huang W, Liang J, Guo J, Ji J, Yao Y, et al. IL4I1 is a novel regulator of M2 macrophage polarization that can inhibit T cell activation via L-Tryptophan and arginine depletion and IL-10 production. PLoS ONE. 2015;10(11):e0142979.","journal-title":"PLoS ONE"},{"issue":"50","key":"7814_CR30","doi-asserted-by":"publisher","first-page":"6092","DOI":"10.1038\/onc.2015.55","volume":"34","author":"DC Koch","year":"2015","unstructured":"Koch DC, Jang HS, O\u2019Donnell EF, Punj S, Kopparapu PR, Bisson WH, et al. Anti-androgen flutamide suppresses hepatocellular carcinoma cell proliferation via the aryl hydrocarbon receptor mediated induction of transforming growth factor-\u03b21. Oncogene. 2015;34(50):6092\u2013104.","journal-title":"Oncogene"},{"issue":"1","key":"7814_CR31","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s12672-024-01000-5","volume":"15","author":"B Chen","year":"2024","unstructured":"Chen B, Liu Y, He Y, Shen C. Pan-cancer analysis of prognostic and immunological role of IL4I1 in human tumors: a bulk omics research and single cell sequencing validation. Discover Oncol. 2024;15(1):139.","journal-title":"Discover Oncol"},{"issue":"1","key":"7814_CR32","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/s10238-025-01795-9","volume":"25","author":"H Soleimani Samarkhazan","year":"2025","unstructured":"Soleimani Samarkhazan H, Shafiei FS, Taghinejad Z, Maleknia M, Noormohamadi H, Raoufi A, et al. The AML immune paradox: decoding escape pathways and pioneering checkpoint, vaccine, and combination strategies. Clin Experimental Med. 2025;25(1):240.","journal-title":"Clin Experimental Med"},{"issue":"4","key":"7814_CR33","doi-asserted-by":"publisher","first-page":"e70106","DOI":"10.1002\/hon.70106","volume":"43","author":"A Bruzzese","year":"2025","unstructured":"Bruzzese A, Vigna E, Martino EA, Labanca C, Carid\u00e0 G, Mendicino F, et al. TP53-Mutated acute myeloid leukemia: unanswered questions. Hematol Oncol. 2025;43(4):e70106.","journal-title":"Hematol Oncol"},{"issue":"1","key":"7814_CR34","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41375-021-01350-x","volume":"36","author":"S Tettamanti","year":"2022","unstructured":"Tettamanti S, Pievani A, Biondi A, Dotti G, Serafini M. Catch me if you can: how AML and its niche escape immunotherapy. Leukemia. 2022;36(1):13\u201322.","journal-title":"Leukemia"},{"issue":"1","key":"7814_CR35","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1186\/s12967-023-04161-z","volume":"21","author":"H Lin","year":"2023","unstructured":"Lin H, Fu L, Li P, Zhu J, Xu Q, Wang Y, et al. Fatty acids metabolism affects the therapeutic effect of anti-PD-1\/PD-L1 in tumor immune microenvironment in clear cell renal cell carcinoma. J Translational Med. 2023;21(1):343.","journal-title":"J Translational Med"},{"issue":"1","key":"7814_CR36","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s10585-022-10189-0","volume":"40","author":"R Mecklenbrauck","year":"2023","unstructured":"Mecklenbrauck R, Heuser M. Resistance to targeted therapies in acute myeloid leukemia. Clin Exp Metastasis. 2023;40(1):33\u201344.","journal-title":"Clin Exp Metastasis"},{"key":"7814_CR37","doi-asserted-by":"crossref","unstructured":"Wu Y, Li Y, Gao Y, Zhang P, Jing Q, Zhang Y, et al. Immunotherapies of acute myeloid leukemia: rationale, clinical evidence and perspective. Biomed Pharmacother. 2024;171:116132.","DOI":"10.1016\/j.biopha.2024.116132"},{"issue":"1","key":"7814_CR38","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41408-024-01143-2","volume":"14","author":"H Kantarjian","year":"2024","unstructured":"Kantarjian H, Borthakur G, Daver N, DiNardo CD, Issa G, Jabbour E, et al. Current status and research directions in acute myeloid leukemia. Blood Cancer J. 2024;14(1):163.","journal-title":"Blood Cancer J"},{"issue":"4","key":"7814_CR39","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1002\/jha2.981","volume":"5","author":"AE Rojek","year":"2024","unstructured":"Rojek AE, McCormick BJ, Cwykiel J, Odetola O, Abaza Y, Nai N, et al. Real-world outcomes of intensive induction approaches in core binding factor acute myeloid leukemia. EJHaem. 2024;5(4):728\u201337.","journal-title":"EJHaem"},{"key":"7814_CR40","doi-asserted-by":"publisher","first-page":"107498","DOI":"10.1016\/j.leukres.2024.107498","volume":"140","author":"MM Morsy","year":"2024","unstructured":"Morsy MM, Azzam AY, Elamin O, Elswedy A, Nashwan AJ. Safety and efficacy of chimeric antigen receptor T-cell therapy for acute myeloid leukemia: A subgroup based meta-analysis. Leuk Res. 2024;140:107498.","journal-title":"Leuk Res"},{"issue":"11","key":"7814_CR41","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1182\/blood.2024024063","volume":"145","author":"S Haubner","year":"2025","unstructured":"Haubner S, Subklewe M, Sadelain M. Honing CAR T cells to tackle acute myeloid leukemia. Blood. 2025;145(11):1113\u201325.","journal-title":"Blood"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-07814-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07814-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07814-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T17:04:39Z","timestamp":1771434279000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-07814-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,12]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7814"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-07814-x","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,12]]},"assertion":[{"value":"30 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were performed in accordance with institutional ethical guidelines and were approved by the Ethics Committee of the First Affiliated Hospital of Fujian Medical University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Animal studies"}},{"value":"N\/A.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"N\/A.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Registry and the registration No. of the study\/trial"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"258"}}